- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.05.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2025 | 756 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2025.ISIN NameCA05259R1073 AUSTRALIS... ► Artikel lesen | |
| 14.05.25 | XFRA DVL: AUSSETZUNG/SUSPENSION | 349 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILALLIANCE PHARMA... ► Artikel lesen | |
| ALLIANCE PHARMA Aktie jetzt für 0€ handeln | |||||
| 13.05.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.05.2025 | 796 | Xetra Newsboard | Das Instrument ZRE CH0042615283 DOCMORRIS AG SF 30 EQUITY wird ex Kapitalmassnahme gehandelt am 13.05.2025 The instrument ZRE CH0042615283 DOCMORRIS AG SF 30 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
| 10.03.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 307 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
| 07.03.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 329 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 07
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
| 06.03.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 384 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 06
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
| 04.03.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 343 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 04
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
| 03.03.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 356 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, March 03
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY... ► Artikel lesen | |
| 28.02.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 460 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, February 28
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE... ► Artikel lesen | |
| 27.02.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 250 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, February 27
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE... ► Artikel lesen | |
| 26.02.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 276 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, February 26
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE... ► Artikel lesen | |
| 25.02.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 295 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, February 25
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE... ► Artikel lesen | |
| 20.02.25 | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc | 340 | PR Newswire | Samson Rock Capital LLP - Form 8.3 - Alliance Pharma Plc
PR Newswire
LONDON, United Kingdom, February 20
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 41,690 | +0,04 % | Billigpille gestoppt: Hims kassiert Wegovy-Klon nach 48 Stunden - Novo-Aktie schießt über 8 % hoch | © Foto: Steffen Trumpf/dpaDer 49-Dollar-Angriff auf Novo Nordisks Wegovy-Pille endet abrupt: Nach Druck der FDA und deutlichen Worten von Novo nimmt Hims das Nachahmerprodukt vom Markt. Novo-Aktien... ► Artikel lesen | |
| PFIZER | 23,245 | +0,13 % | FDA prüft Zulassungserweiterung für Pfizers Hämophilie-Medikament Hympavzi | Die US-Arzneimittelbehörde FDA hat dem Pharmakonzern Pfizer für das Hämophilie-Medikament Hympavzi eine vorrangige Prüfung einer beantragten Zulassungserweiterung eingeräumt. Der ergänzende Antrag betrifft... ► Artikel lesen | |
| SANOFI | 78,09 | -0,13 % | Sanofi holt Merck-Chefin Garijo als CEO | DJ Sanofi holt Merck-Chefin Garijo als CEO
Von Billy Gray
DOW JONES--Sanofi wechselt den CEO aus. Wie der französische Pharmakonzern mitteilte, hat er das Mandat von Paul Hudson nicht verlängert.... ► Artikel lesen | |
| GSK | 24,860 | +0,97 % | JEFFERIES stuft GSK auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für GSK von 2100 auf 2450 Pence angehoben und die Einstufung auf "Buy" belassen. Die Aktie des Pharmakonzerns habe zuletzt kräftig... ► Artikel lesen | |
| INCYTE | 85,18 | +0,02 % | Incyte Corporation Q4 Profit Increases, Beats Estimates | WASHINGTON (dpa-AFX) - Incyte Corporation (INCY) announced earnings for its fourth quarter that Increased from last year and beat the Street estimates.The company's bottom line totaled $299.3... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 68,62 | +1,06 % | EU Approves DAWNZERA For Hereditary Angioedema, Says Ionis And Otsuka | TOKYO (dpa-AFX) - Ionis Pharmaceuticals, Inc. (IONS) and Otsuka Pharmaceutical Co., Ltd. on Wednesday said the European Commission has approved Dawnzera to prevent repeated attacks of hereditary... ► Artikel lesen | |
| CSPC PHARMA | 1,112 | +1,83 % | HSI Closes at 27,183, Up 155 pts; HSTI Closes at 5,451, Up 33 pts; CSPC PHARMA Up over 5%; ZTO EXPRESS-W, WH GROUP, BOC HONG KONG, WHARF REIC, HANG LUNG PPT Hit New Highs; Market Turnover Rises | ||
| ALNYLAM PHARMACEUTICALS | 265,50 | +0,45 % | Alnylam Pharmaceuticals Reports Net Income In Q4 | WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY) reported fourth quarter net income of $111.5 million compared to a loss of $83.8 million, prior year. GAAP net income per common share... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 3,060 | +1,32 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) | Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the... ► Artikel lesen | |
| TRULIEVE CANNABIS | 5,455 | +1,49 % | Trulieve Cannabis Corp: Trulieve Cannabis to release 2025 results Feb. 26 | ||
| ACADIA PHARMACEUTICALS | 18,415 | -0,78 % | Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union | - Company expects to receive a negative opinion following oral explanation feedback and intends to request re-examination upon review of formal adoption.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD)... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 19,770 | -3,51 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 | ||
| MADRIGAL PHARMACEUTICALS | 390,20 | -0,13 % | Suzhou Ribo Life Science Co., Ltd.: Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH | SUZHOU, China and MÖLNDAL, Sweden, Feb. 11, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") today... ► Artikel lesen | |
| WEST PHARMACEUTICAL SERVICES | 208,70 | -1,09 % | West Pharmaceutical Q4 Earnings Rise; Guides FY26 | WASHINGTON (dpa-AFX) - West Pharmaceutical Services, Inc. (WST), on Thursday, reported its higher net income in the fourth quarter compared with the previous year and issued an outlook for the... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,052 | +30,00 % | ENZON PHARMACEUTICALS, INC. - 8-K, Current Report |
Das Unternehmen ALLIANCE PHARMA PLC kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,670 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALLIANCE PHARMA PLC finden Sie auf Wallstreet Online.